维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="THOMSSEN C"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	High risk of squamous cell carcinoma of the cervix for woman with HLA-DQw3显示文摘	Wank R Thomssen C	1991	Nature1991，352，6337：	1
2	Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy 显示文摘	Schmitt M Harbeck N Thomssen C	1997	Thromb Haemost1997，78，1：	1
3	The future of breast cancer management显示文摘	Harbeek N Jakesz R Thomssen C	2008	Breast Care (Basel)2008，3，6：	1
4	High risk of squamous cell carcinoma of thecervix for women with HLA-DQw3 显示文摘	Wank R Thomssen C	1991	Nature1991，352，6337：	1
5	ClinieaI impact of the plasminogen activation system in tumor invasion and metastasis:prognostic relevance and target for therapy显示文摘	Harbeck N Thomssen C	1997	Thromb Hemost1997，78，1：	1
6	A new look at node-negative breast cancer显示文摘	Harbeck N Thomssen C	2011	Oncologist2011，16，1：	1
7	High risk of squamous cell carcinoma of the cervix for woman with HLA-DQW3显示文摘	WANK R THOMSSEN C	1991	Nature1991，352，：	1
8	Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer 显示文摘	Dettermar P Harbeck N Thomssen C	1997	Br J Cancer1997，75，：	1
9	High risk ofsquamous cell carcinoma of the cervix for women with HLA-DQw3 显示文摘	Wan kR Thomssen C	1991	Nature1991，352，6337：	1
10	Multicentric phase study in first line treatment of advanced metastatic breast cancer Epirubicin/Paclitaxel vs epirubicin/cyclophosplamide,a study of the ago breast cancer group显示文摘	Thomssen C Untch M	2000	Proc Am Soc Oncol2000，19，：	1
11	High risk of squamous cell carcinoma of the cervix for women with HLA -DQw3 显示文摘	Wank R Thomssen C	1991	Nature1991，352，6337：	1
12	Human CD4-CD8-alpha beta + T-call receptor T cells recognize different mycobacteria strains in the context of CD1b显示文摘	Thomssen H Ivanyi J Espitia C	1995	Immunology1995，85，1：	1
13	HER-2/neu gene ampli- fication and response to paclitaxel in patients with metastatic breast cancer显示文摘	Konecny GE Thomssen C Liick HJ	2004	J Nat Cancer Ins2004，96，15：	1
14	Clinical impact of the plas minogen actibation system in tumor invasion and metastasis:prognostee relevance and target for therapy显示文摘	Schmitt M Harbeck N Thomssen C	1997	Thrombosis Haemostasis1997，78，1：	1
15	High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3显示文摘	Wank R Thomssen C	1991	Nature1991，352，6337：	1
16	Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 显示文摘	Jfinicke F Prechtl A Thomssen C German NO Study Group	2001	J Natl Cancer Inst2001，93，12：	1
17	Clinical impact of the plaminogen activation system in tumor invasion and metastasis prognostic relevance and target for therapy显示文摘	Schmitt M Harbeck N Thomssen C	1997	Thrombosis Haemostssis1997，78，4：	1
18	Tolerability and efficacy of first-line bevacizumab (B)plus chemotherapy(CT)in elderly patients with advanced breast cancer (ABC):Subpopulation analysis of the MO19319 study显示文摘	Biganzoli L Cortes-Funes H Thomssen C	2009	J Clin Oncol2009，27，15：	1
19	Clinical impact of the plasminogen activation system in tumor invasion and metastasis prognostic relevance and target for therapy显示文摘	Schmitt M Harbeck N Thomssen C		0，，：	1
20	Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy显示文摘	SCHMITT M HARBECK N THOMSSEN C	1997	Thromb Haemost1997，78，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示